Hyperprolactinaemia and pituitary adenomas in adolescence

Journal of Pediatric Endocrinology and Metabolism

Volumn 11, Issue 4, 1998, Pages 531-541

  Dissaneevate, Pathikan ^a   Warne, Garry L ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Adolescence; Children; Hyperprolactinaemia; Pituitary adenoma

Indexed keywords

BROMOCRIPTINE; PROLACTIN;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CRANIOTOMY; FEMALE; GALACTORRHEA; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; MALE; PROLACTIN RELEASE; PUBERTY; TREATMENT INDICATION;

EID: 0031691739     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1998.11.4.531     Document Type: Article

References (60)

1. Van Meter QL, Gareis FJ, Hayes JW, Wilson CB. Galactorrhoea in a 12-year old boy with a chromophobe adenoma. J Pediatr 1977; 90: 756-759.
2. Lucas C, Guibout M, Jaquet P, Grisoli F, Giraud F. Aspects diagnostiques et évolutifs de l'adenoma a prolactine chez l'enfant, [in French] Arch Fr Pediatr 1980; 37: 79-86. (Abstract)
3. Sinn DH, Grossman A, Jones AE, Domiach I, Connolly C, Ress LH, Besser GM, Savage MO. Prolactinoma in a prepubertal child; response to surgery, radiotherapy and dopamine agonist therapy. Pediatr Res 1985; 19: 612.
4. Tyson D, Reggiardo D, Sklar C, David R. Prolactin-secreting macroadenomas in adolescents: response to bromocriptine therapy. Am J Dis Child 1993; 147: 1057-1061.
5. Kulah A, Erel C, Memis M, Sav A. Arrested puberty associated with apoplectic prolactinoma in a male adolescent. Childs Nerv Syst 1995; 11: 124-127.
6. De Kerdanet M, Lebrethon MC, Lecorum M. Prolactin-secreting macroadenoma in an adolescent girl: response to the medical treatment and follow-up method, [in French] Pédiatrie 1993; 48: 223-226. (Abstract)
7. Billaud L, Cousin I, Guilhaume B, Luton JP. Prolactin adenoma developed during puberty. Diagnosis and long-term course. 9 cases, [in French] Presse Med 1993; 22: 299-303. (Abstract)
8. Oliveira M da C, Abech DD, Barbosa-Coutinho LM, Ferreira NP. Macroprolactinoma at 6 years of age: diagnostic difficulties, [in Portuguese] Arq Neuropsiquiatr 1992; 50: 397-401. (Abstract)
9. Mindermann T, Wilson CB. Pediatric pituitary adenomas. Neurosurgery 1995; 36: 259-269.
10. Jaruratanasirikul S, Janejindamai S. Idiopathic hyperprolactinemia in a 15-year-old boy: A case report and literature review. J Med Assoc Thai 1995; 78: 388-391.
11. Sack J, Friedman E, Tadmor R, Sahar A, Katznelson D. Growth and puberty arrest due to prolactinoma. Acta Pediatr Scand 1984; 73: 863-867.
12. Triwary C. Prolactinoma in an adolescent girl: unusual response to bromocriptine therapy. Am J Dis Child 1989; 143: 521-523.
13. Dandona P, Mohiuddin J, Lindsay KW. Galactorrhea following hypophysectomy in a boy with a prolactinoma. Postgrad Med J 1984; 60: 540-541.
14. Kamel N, Uysal AR, Cesur V, Erogan G, Baskal N. Normal growth and puberty development during bromocriptine therapy in two patients with prolactinoma. Endocrine J 1995; 42: 581-586.
15. Mindermann T, Wilson CB. Pituitary adenomas in childhood and adolescence. J Pediatr Endocrinol Metab 1995; 8: 79-83.
16. Laws ER, Scheithauer BW, Groover RV. Pituitary adenoma in children and adolescents. Prog Exp Tumor Res 1987; 30: 359-361.
17. Maira G, Anile C. Pituitary adenomas in childhood and adolescence. Can J Neurol Sci 1990; 17: 83-87.
18. Ross RJM, McEniery JM, Grossman A, Doniach I, Besser GM, Savage MO. Massive prolactinoma with galactorrhoea in a prepubertal boy. Postgrad Med J 1989; 65: 403-406.
19. Minniti G, Jaffrain-Rea ML, Lunardi P, Gulino A, Tamburrano G. 15-year-old boy with ocular palsy and headache. Eur J Pediatr 1996; 155: 717-719.
20. Kane LA, Leinung MC, Scheithauer BW, Bergstralh EJ, Laws Jr. ER, Groover RV, Kovacs K, Horvath E, Zimmerman D. Pituitary adenomas in childhood and adolescence. J Clin Endocrinol Metab 1994; 79: 1135-1140.
21. Partington MD, Davis DH, Laws ER Jr, Scheithauer BW. Pituitary adenomas in childhood and adolescence: results of transsphenoidal surgery. J Neurosurg 1994; 80: 209-216.
22. Dyer EH, Civit T, Visot A, Delalande O, Derome P. Transsphenoidal surgery for pituitary adenomas in children. Neurosurgery 1994; 34: 207-212.
23. Haddad SF, VanGilder JC, Menezes AH. Pediatric pituitary tumors. Neurosurgery 1991; 29: 509-514.
24. Hewlett TA, Wass JAH, Grossman A, Plowman PN, Charlesworth M, Touzel R, Ress LH, Savage MO, Besser GM. Prolactinomas presenting as primary amenorrhoea and delayed or arrested puberty: response to medical therapy. Clin Endocrinol 1989; 30: 131-140.
25. Schroffner WG. Prolactin-secreting pituitary tumor in early adolescence. Arch Intern Med 1976; 136: 1164-1168.
26. Pertzelan A, Bauman B, Gurewitz R, Matz S, Silbergeld A, Laron Z. Prolactin secreting pituitary adenoma in childhood and adolescence. Adv Biosci 1988; 69: 303-307.
27. Slonim AE, Glick AD, Island DP, Kasselberg AG. Hyperprolactinemia associated with advanced puberty in a male. J Pediatr 1982; 101: 236-239.
28. Beck W, Stubbe P, Ludecke D. Prolactin-producing pituitary adenoma in a 9 year old boy. Eur J Pediatr 1979; 130: 193-198.
29. Kauli R, Schoenfeld A, Ovadia Y, Math S, Assa S, Laron Z. Delayed puberty and hypoplastic uterus associated with hyperprolactinemia: successful treatment with bromocriptine. Horm Res 1985; 22: 68-73.
30. Sadeghi-Nejad A, Wolfedorf JI, Biller BJ, Post KD, Senior B. Hyperprolactinemia causing primary amenorrhea. J Pediatr 1981; 99: 802-804.
31. Grisoli F, Guibout M, Jaquet P, Michotey P, Mouly A, Lucas C. Pubertal prolactin adenoma. Eight cases, [in French] Nouv Presse Med 1978; 7: 1819-1825. (Abstract)
32. Barrio R, Roger M, Chaussain JL, Job JC. Prolactin-secreting pituitary adenomas in children and adolescents. Study of a series of 8 cases, [in French] Arch Franc Pediat 1979; 36: 785-793. (Abstract)
33. Koenig MP, Zuppinger K, Liechti B. Hyperprolactinemia as a cause of delayed puberty: successful treatment with bromocriptine. J Clin Endocrinol Metab. 1977; 45: 825-828.
34. Minniti G, Jaffrain-Rea ML, Ferretti E, Gulino A, Tumburrano G. Macroprolactinomas as cause of delayed puberty. Minerva Endocrinol 1996; 21: 67-71. (Abstract)
35. Randall RV, Laws ER, Abboud CF, Ebersold MJ, Kao PC, Scheithauer BW. Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas: results in 100 patients. Mayo Clin Proc 1983: 58: 108-121.
36. Mori H, Mori S, Saitoh Y, Arita N, Aono T, Uozumi T, Mogami H, Matsumoto K. Effects of bromocriptine on prolactin-secreting pituitary adenomas. Cancer 1985: 56: 230-238.
37. Bevan JS, Webster J, Burke CW, Scanlon MF. Dopamine agonists and pituitary tumour shrinkage. Endocr Rev 1992; 13: 220-240.
38. Huseman CA, Rizk G, Hahn F. Long-term bromocriptine treatment for prolactin-secreting macroadenoma. Am J Dis Child 1986; 140: 1216-1217.
39. Cunnah D, Besser M. Management of prolactinomas. Clin Endocrinol 1991; 34: 231-235.
40. Vance ML, Thorner MO. Prolactinomas. Endocrinol Metab Clin North Am 1987; 16: 731-753.
41. Dalkin AC, Marshall JC. Medical therapy of hyperprolactinemia. Endocrinol Metab Clin North Am 1989; 18: 259-276.
42. Peillon F, Dupuy M, Li JY, Kujas M, Vincens M, Mowszowicz I, Derome P. Pituitary enlargement with suprasellar extension functional hyperprolactinemia due to lactotroph hyperplasia: A pseudotumoral disease. J Clin Endocrinol Metab 1991; 73: 1008-1015.
43. Wass JAH, Williams J, Charlesworth M, Kingsley DP, Halliday AM, Doniach I, Rees LH, McDonald WI, Besser GM. Bromocriptine in management of large pituitary tumours. BMJ 1982; 284: 1908-1911.
44. Molitch ME, Thorner MO, Wilson C. Management of prolactinomas. J Clin Endocrinol Metab 1997; 82: 996-1000.
45. th Ed. St. Louis, MO: Mosby-Year Book, 1994; 38-43.
46. Soule, SG. Prolactinomas: present day management. Br J Obstet Gynaecol 1995; 102: 178-181.
47. Molitch ME, Elton RL, Blackwell RE, Caldwell B, Chang RJ, Joplin G, Robbins RJ, Tyson J, Thorner MO, and the bromocriptine study group. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab 1985; 60: 698-705.
48. Blackwell RE. Hyperprolactinaemia evaluation and management. Endocrinol Metab Clin North Am 1992; 21: 105-124.
49. Alford FP, Arnott R. Medical management of pituitary tumours. Med J Aust 1992; 157: 57-60.
50. Brue T, Pellegrini I, Prion A, Morange I, Jaquet P. Prolactinomas and resistance to dopamine agonist. Horm Res 1992; 38: 84-89.
51. Mehta AE, Reyes FI, Faiman C. Primary radiotherapy of prolactinomas. Am J Med. 1987; 83: 49-58.
52. Rains CP, Bryson HM, Fitton A. Cabergoline: a review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation. Drugs 1995; 49: 255-279.
53. Ferrari C, Mattei A, Melis GB, Paracchi A, Muratori M, Faglia G, Sghedoni D, Crosignani PG. Cabergoline: long-acting oral treatment of hyperprolactinemic disorder. J Clin Endocrinol Metab 1989; 68: 1201-1206.
54. Ferrari CI, Abs R, Bevan JS, Brabant G, Ciccarelli E, Motta T, Mucci M, Muratori M, Musatti L, Verbessem G, Scanlon MF. Treatment of macroprolactinoma with cabergoline: a study of 85 patients. Clin Endocrinol 1997; 46: 409-413.
55. Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF. A comparison of Cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med 1994; 331: 904-909.
56. Molitch, ME. Pathological hyperprolactinaemia. Endocrinol Metab Clin North Am 1992; 21: 877-901.
57. Livesey EA, Hindmarsh PC, Brook CGD, Whitton AC, Bloom HJG, Tobias JS, Godlee IN, Britton J. Endocrine disorders following treatment of childhood brain tumors. Br J Cancer 1990; 61: 622-625.
58. Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, Rubin P. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 1993; 328: 87-94.
59. Rappaport R, Brauner R. Growth and endocrine disorders secondary to cranial irradiation. Pediatr Res 1989; 25: 561-567.
60. Rappaport R, Brauner R, Czernichow P, Thiband E, Renier D, Zucker JM, Lemerle J. Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. J Clin Endocrinol Metab 1982; 54: 1164-1168.